California: HIVers Needed for Flu Remedy Study
November 17, 2009
HIV-positive Bay Area residents who have influenza can apply to enroll in a study of a new triple combination antiviral drug (TCAD) against the seasonal infection, researchers told a Nov. 10 San Francisco forum on flu and HIV/AIDS. Persons who call the Flu Hotline, set up by Quest Clinical Studies and Conant Medical Group, and are accepted into the trial will be treated at home and will receive compensation for their time and travel.
"There hasn't been a lot of vaccine available in San Francisco," said Lalezari. "Most of the HIV-positive patients have not been able to vaccinate" against seasonal flu, and neither have staff working on the study, he said.
"If you have not had the Pneumovax in the last five years you should get it," area Dr. Marcus Conant advised the approximately 40 attendees. "It will reduce your risk of pneumonia. HIV-positive patients should usually get it every five years."
The study's Flu Hotline is 1-888-5-HIV-FLU (1-888-544-8358).
Bay Area Reporter (San Francisco)
U.S. Clinical Trials Show Single Dose of H1N1 Vaccine Protects Pregnant Women, Children Under 10 Need Two Doses
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.